All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| XGN / Exagen Inc.
|
|
|
|
|
|
|
|
| MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd. Call
|
|
|
|
|
|
|
|
| XENT / Intersect ENT Inc
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
| REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ICUI / ICU Medical, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| PTN / Palatin Technologies, Inc.
|
|
|
|
|
|
|
|
| SLGL / Sol-Gel Technologies Ltd.
|
|
|
|
|
|
|
|
| SIBN / SI-BONE, Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
| MTNB / Matinas BioPharma Holdings, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| SSKN / STRATA Skin Sciences, Inc.
|
|
|
|
|
|
|
|
| SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
| 98235T107 / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
| ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| 018490100 / Allergan plc
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
| XCUR / Exicure, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
